Gefen Megurim in the first quarter: the cash arrived, the proof moved to Jabotinsky
Gefen Megurim entered the first quarter with new funding: NIS 20 million of credit, NIS 14.2 million from the CEO, and NIS 50 million from Leumi Partners after the balance-sheet date. But operating cash flow is still negative, and future growth now runs through a joint company, expensive debt, and a Jabotinsky project that must reach financing on time.
Gefen Megurim reported a quarter that solves a meaningful part of the early 2026 liquidity question, but still does not prove that its pipeline has become a cash-generating business. The cash did arrive: cash and equivalents rose to NIS 26.5 million at the end of March, a NIS 20 million credit facility was fully drawn, CEO Nati Gilboa invested NIS 14.2 million, and after the balance-sheet date Leumi Partners completed a NIS 50 million investment. That is real progress versus the previous funding analysis, which framed 2026 as a year in which capital sources mattered almost as much as permits. Still, the source of the improvement is funding and equity, not apartment sales: operating cash flow was negative by NIS 9 million in the quarter, no major project has started marketing, and the company has not yet recognized gross profit from the projects that are supposed to change its scale. Leumi is not only adding cash, it changes the economics of the next growth layer: future projects are expected to move into a joint company where the listed company owns 80%, alongside high-cost debt, management fees, and a company guarantee. The quarter therefore moves the test to two near-term checkpoints: financial close for Jabotinsky within the credit facility's time window, and real permit or marketing progress at Jabotinsky, Pladot, and Yavne toward the end of 2026.
The Cash Came From Outside, Not From Projects
The company is an early-stage urban-renewal developer. Its recurring revenue barely tells the story: first-quarter rental revenue was only NIS 20 thousand, while the balance sheet carries building and land inventory of NIS 232.5 million. This is not a current earnings machine. It is an asset, funding, and permitting machine. Value is supposed to be created when projects move from signatures and planning to permits, financing, marketing, and gross-profit recognition.
The all-in cash picture for the quarter is clear: after the quarter's actual cash uses, the increase in cash came almost entirely from financing. Operating cash flow consumed NIS 9 million, investing cash flow was negligible, and financing cash flow contributed NIS 29 million, mainly from new credit and the private placement to the CEO. Cash and equivalents therefore rose from NIS 6.5 million at the end of 2025 to NIS 26.5 million at the end of March 2026.
The quality of the improvement matters more than the direction. Building and land inventory continued to grow, and the operating-cash-flow adjustments included a NIS 4.9 million increase in building and land inventory plus another NIS 0.35 million increase in advances for land inventory. The company also paid NIS 1.75 million of interest in the quarter. Twelve-month working capital turned positive by about NIS 2.9 million on a consolidated basis, improving the year-end 2025 picture, but the board still refers to continuing negative operating cash flow. The company bought financing room, not operating proof.
Jabotinsky Became A Funding Anchor Too
The previous annual analysis framed 2026 as a proof year dependent on permits, capital, and two Ashdod anchors. The Ashdod concentration analysis sharpened that dependence through Jabotinsky and Pladot. The first quarter does not close that test, but it gives Jabotinsky an additional role: not only a project with expected gross profit, but also the project supporting the new credit facility.
The NIS 20 million facility is non-revolving, valid until January 25, 2028, and secured by the Jabotinsky project in Ashdod. As of the financial-statement approval date, the company had drawn the full facility. If project financing is not signed within nine months from the agreement date, the lender may demand repayment of all or part of the loans, or cancel the facility. The agreement was signed on January 25, 2026, so around late October 2026 Jabotinsky needs to be in a different place: high signatures and approved zoning are not enough. The project needs financing.
| Project | Expected marketing or permit timing | Signatures | Company-share units for sale | Expected gross profit in company share | Still missing |
|---|---|---|---|---|---|
| Jabotinsky, Ashdod | Oct-Dec 2026 | 95% | 397 | NIS 146.1 million | Financing, permit, and actual marketing |
| Pladot, Ashdod | Oct-Dec 2026 | 98% | 395 | NIS 140.4 million | Financing, permit, and actual marketing |
| Ha'atzmaut, Yavne | Oct-Dec 2026 | 96% | 79 | NIS 38.7 million | Permit, financing, and contractor |
| Alkalai, Petah Tikva | Jul-Sep 2027 | 86% | 114 | NIS 58.4 million | First permit |
The table shows the gap between planning maturity and proven economics. Jabotinsky includes vacating 124 existing units and building about 521 units and 1,850 square meters of commercial space, with 95% of tenants signed on binding evacuation-construction agreements. Pladot is already at 98% signatures, but the company's share is 35% alongside Tidhar, so the project headline is larger than the direct economics to the public company. In both anchors, marketing has not started, no gross profit has been recognized, and no project financing agreement had been signed by the report publication date.
Leumi Adds Power, But The Next Growth Layer Is Shared
The Leumi Partners transaction is the quarter's most important event, even though completion took place after the balance-sheet date. The company received NIS 50 million against the issuance of 62.5 million shares at NIS 0.80 per share, and Leumi also received 56.6 million non-tradable warrants at the same exercise price for 5 years. At the cash level, this is a major step forward. At the public-shareholder level, it is also dilution and a change in how future economics are shared.
All existing projects remain with the company, but every future project in the joint company's activity field will be acquired and executed only through Gefen Yazamut, where the company owns 80% and Leumi Partners owns 20%. Future growth from acquiring new urban-renewal compounds or companies that promote them will therefore no longer fully accrue to public shareholders.
The debt layer of Gefen Yazamut is not cheap. Leumi Partners is expected to provide a NIS 150 million loan to the joint company in three NIS 50 million installments, within 3, 6, and 9 months from completion or earlier at the joint company's request. The loan bears fixed annual interest of 8% to 9%, half current and half accrued, plus annual management fees of 3% on the outstanding principal. Leumi may also provide two additional NIS 150 million loans, but those are rights at Leumi's discretion, not a hard commitment.
The transaction meaningfully improves operating capacity, adds an institutional partner, and creates a path to expand activity. But it also means the next growth layer will be leveraged, shared, and carry a meaningful cost of capital. The loan to Gefen Yazamut will be secured, among other things, by pledges over project-company shares, a floating charge over their assets, and a company guarantee for 80% of the credit amounts. This funding creates purchasing power, but it does not eliminate the repayment and project-financing tests.
Conclusions
The first quarter improves the starting point for 2026, but it does not close the proof test. The company replaced much of the funding uncertainty with signed capital and an institutional partner, and that is a real change. But it still needs to prove that the new money turns into permits, project financing, and marketing, not only into a funding layer that supports a larger pipeline.
Management frames 2026 as a permit year for hundreds of units, alongside workforce expansion and partnerships with institutional bodies. That is proof-year language, not full earnings-year language. The presentation also shows that revenue and gross-profit recognition are expected to be back-loaded: about NIS 164 million of revenue and NIS 29 million of gross profit are expected in 2027-2028, versus about NIS 1.33 billion of revenue and NIS 241 million of gross profit in 2029-2030.
The current read is that the funding side improved while execution remains unproven. The strongest counter-thesis is that the Leumi transaction and high signature rates are enough to accelerate the company, especially if Jabotinsky and Pladot reach marketing in the fourth quarter of 2026. Until then, the picture is simpler: the cash came from outside, project profit is still ahead, and Jabotinsky has become the first proof point the market will measure. A Jabotinsky financing agreement can change the interpretation quickly. Additional quarters of negative operating cash flow without permit or marketing progress would move the debate back from pipeline quality to funding quality.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.